Detalhe da pesquisa
1.
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial.
Lancet Oncol
; 25(4): 463-473, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467131
2.
High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.
Haematologica
; 104(11): 2249-2257, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30890600
3.
Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma.
Haematologica
; 102(4): 765-772, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011903
4.
The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.
Ann Hematol
; 92(1): 97-100, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22956183
5.
Collaborative cytometric inter-laboratory ring test for probiotics quantification.
Front Microbiol
; 14: 1285075, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029213
6.
Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
Cancer Genet
; 206(3): 49-62, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23531595
7.
DNA methylation dynamics in blood after hematopoietic cell transplant.
PLoS One
; 8(2): e56931, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23451113
8.
Common infectious agents and monoclonal B-cell lymphocytosis: a cross-sectional epidemiological study among healthy adults.
PLoS One
; 7(12): e52808, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23285188